Neurogenetics and DNA laboratory

1. Neurogenetics and DNA laboratory Pavel Seeman CMT team Prague

2. Neurogenetics „neurology of the whole family“ for clinicians : ask about and investigate the relatives !

3. DNA laboratory in neurological departments at 2nd School of Medicine, Charles University and University Hospital Motol Prague Dept of Child Neurology(Hereditary Neuropathies, Pelizaeus Merzbacher disease,Nijmegen Breakage Syndrome) Dept of Adult Neurology(Hereditary Neuropathies)CMT Dept of Pediatric Otorhinolaryngology(Congenital Nonsyndromic Deafness – Connexin 26)

4. DNA testing for CMT in Czech Rep • DNA testing for CMT in the Czech Republic available since 1997 – still the only lab testing for CMT • Grants of Ministery of Health of Czech Republic • All DNA samples and patient data from CMT patients in one lab – many advantages and great potential

5. Hereditary neuropathies – Charcot-Marie-Tooth diseases • Most common group of genetically caused neuromuscular diseases – (1: 2 500 – 5 000) • Genetically very heterogeneus group – now mutations in 23 genes can cause CMT • Highly prevalent mutation is the CMT1A duplication / HNPP deletion on chromosome 17p incl. PMP22 gene • Challenge for the detection methods – to small for cytogenetics, to big for molecular genetics and to close together for conventional metaphase FISH

7. Detection of the most common mutation in CMT in DNA laboratory Set 58°C Set 55°C now: 15 microsatellites markers located within the duplicated CMT1A region

8. Detection of point mutations in further genes in patients with excluded CMT1A/HNPP In patients where we have enough clinical data ! • Connexin 32 gen (GJB1) – in CMTX • Myelin protein zero (MPZ) – in severe demyelinating forms and in axonal form • PMP22 gene – in demyelinating forms • LITAF gene – in demyelinating dominant forms

9. Czech CMT families 1997 - 2003 548 - families tested1271 – individuals mutation detected in total 238 families 268 individual gene tests CMT1A: 258 individuals, HNPP: 131 individuals

10. CMT families with enough clinical data – 408 families in 140 families out of 548 not enough clinical data were provided 408 families with sufficient clinical data

11. Modes of inheritance in Czech CMT patients cohort In 392 families – unrelated patients with suficient family information

12. Gene testing – sequencing in CMT patients without the CMT1A duplication

13. Connexin 32 gen, GJB1 • X- linked dominant • expressed in PNS as well as in CNS • mutations in Cx32 are the second most common cause of CMT (after CMT1A )

14. Connexin 32 gene, GJB1 • Investigated: 58 families without CMT1A duplication • Causal mutation found in 21 families (36,2 %) • Among 46 familiar cases only 45,6% • Families positive for Cx32 mutation were always large many members affected by CMT • One family, possibly a de-novo mutation • 6 families from 13 (46%) – carry the same mutation Glu208Lys – haplotype analysis showed a founder efect – all 6 large families have a common founder

15. Mutation Glu208Lys in Cx32 in 6 large Czech families is due to a founder efect.

16. Myelin Protein Zero (MPZ) (P0) gene • expressed in PNS only in myelinated Schwann cells – in central involvement • 4 clinical phenotypes – due to a mutation in MPZ – – CMT1 classical (demyel.) - DSS or HMSN III- early onset severe demyel. - congenital hypomyelination (CHN)–very early onset - CMT 2 (axonal) late onset

17. MPZ (P0) gene • investigated: 80 families without CMT1A duplication • mutation found in 8 families (10 %) • 4x axonal form a 4x demyelinating severe form • Arg98Cys mutation 2x – in two families de-novo – hot-spot

18. PMP22 gene • expression only in PNS – no signs of central involvement • dominant mutations – heterozygotes are affected • phenotype – CMT1 classical - Dejerine Sottas or congenital hypomyelination • PMP22 mutations are rare worldwide

19. PMP 22 gene • all coding exons sequenced in – 33 families/unrelated patients without CMT1A duplication • mutation found in 1 patient only ( 3%) – sporadic case, congenital hypomyelination (CHN) – de-novo mutation Ser72Leu • point mutations in PMP22 are rare

20. LITAF 1/ SIMPLE gene • Lipopolysacharide-Induced Tumor necrosis Alfa Factor - Small Integral Mebrane Protein of the Lysosome/late Endosome • 3codingexons, 486 bp, 161 AA • Street et al. 2003 – Neurology 60: 22-26 Mutation in LITAF/SIMPLE in CMT1C disease. • 46 CMT1 families tested • 2 causal mutations detected (>5 %), one is Gly113Ser in a family with very mild CMT • Many polymorfisms incl. Ile92Val, Thr78Thr

21. Two different phenotypes caused by P0/MPZ mutation

22. Czech family with axonal CMT beginning with deafness

23. Family F.

24. Family F. • hearing loss and deafness as the first symptom of CMT disease - at the late teens in the grandfather and in the mother - progressive hearing loss, deafness now • abnormal pupillar reaction before the onset of the neuropathy • fully normal physical abilities until the end of 3rd decade • late onset of polyneuropathy of axonal type - slow progression at the grandfather but quite fast at the mother, 12 years old boy clinically still unaffected • whorsening of electrophysiological and clinical findings correlated with higher age in the family – axonal loss and later demyelination

26. no pes cavus, severe footdrop pronounced hand muscles atrophies

27. Audiograms mother(622) son(623)

28. Electrophysiology Axonal polyneuropathy – very low amplitudes with preserved NCVs

29. Nerve and muscle biopsy in nr. 622 (mother) nerve muscle Normal control Normal control

30. 290 A>T (Glu97Val) in MPZ gene

31. Dejerine Sottas neuropathy and MPZ mutation • Deafness as late symptom in DSN patients

32. Family K. • Mutation Arg98Cys - neighbour aminoacid to the previous family

33. Family K. • Mother (44y.) and son (18y.) severely affected (HMSN III or DSN), no other affected members in the family • early onset (3 y.) with hypotonia, delayed motor milestones, scoliosis, both affected never achieved normal independent gait • distal weakness and atrophies, areflexia, rather nonprogressive course • extremely decreased MNCV ( 8-10 m/s), absent SNAP • hypertrofic demyelinating neuropathy (with onion- bulbs) in the sural nerve biopsy in the mother • in the mother from the age of 25 y. - hearing loss, presently sensorineural hearing loss bilateral ( up to 70 dB)both affected showed abnormal pupillar reaction

34. Family K. son mother

35. Family K. mother son no foot deformities

36. Other, recently discovered genes in CMT(to be screened in the future in „unknown“ patients) • PRX - AR demyel • GDAP1 - AR - demyel., axonal and intermediar. • MTMR2 - AR – focally folded myelin • NEFL - AD - axonal and demyel • LITAF/SIMPLE - CMT1C - AD, demyel. • LMNA - AR - axonal • RAB 7 - AD – axonal with ulcers • NDRG1 - HMSN Lom - Bulgaria • GAN - giant axonal neuropathy • NTRK 1 - HSAN IV • SPTLC1 - HSN I

37. Larger families with unknown mutation – linkage studies – new candidate genes discoveries HMN II and 12q24 locus

38. Linkage analysis to localize possible new „CMT genes“ AD CMT family, CMT1A, MPZ excluded

39. Linkage analysis to localize possible new „CMT genes“ AD-CMT family,CMT1A, MPZ, PMP22 mutations excludedelectrophysiology intermediate